stockrow
Saturday 7 November 2026
Export HITI’s income statement to Excel — free account
High Tide Inc.
HITI Healthcare Pharmaceutical Retailers
High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024.
- Revenue
- +30.7%
- EPS
- +800.0%
- Free cash flow
- −7.91%
- Total debt
- +54.7%
Quarter to July 2026, against a year earlier
2.63
0.00
0.00%
Follow HITI
Alert me
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.36 | 0.44 | 0.44 | 0.60 | |
P/FCF ratio |
16.97 | 18.42 | 14.44 | 26.38 | |
P/Operating CF |
26.65 | 65.42 | 46.70 | 91.81 | |
P/B ratio |
2.20 | 2.89 | 2.68 | 3.48 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.45 | 0.53 | 0.52 | 0.69 | |
EV/EBITDA |
13.22 | 17.95 | 22.95 | 41.43 | |
EV/Operating CF |
13.51 | 14.21 | 11.40 | 17.12 | |
EV/FCF |
21.07 | 22.28 | 17.33 | 30.10 | |
Quick Ratio |
0.59 | 0.49 | 0.59 | 0.54 | |
Current Ratio |
1.50 | 1.46 | 1.43 | 1.37 | |
Net Debt/EBITDA |
4.23 | 5.00 | 5.27 | (3.78) | |
Debt/Assets |
30.07% | 28.23% | 29.22% | 28.22% | |
Debt/Equity |
0.93 | 0.96 | 0.99 | 0.96 | |
Asset Turnover |
2.29 | 2.33 | 2.18 | 1.97 | |
Operating CF/Net income |
0.88 | (22.82) | 4.86 | (0.09) | |
Capex/Depreciation |
(0.29) | (0.28) | (0.28) | (0.48) | |
Interest Coverage |
1.56 | 1.17 | 0.39 | (4.89) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.25% | 16.91% | 16.72% | 16.63% | |
Intangible Assets out of Total Assets |
0.35 | 0.36 | 0.37 | 0.37 | |
Share Based Compensation of Revenue |
0.43% | 0.49% | 0.21% | 0.37% | |
Graham Net Nets |
(0.39) | (0.39) | (0.40) | (0.31) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(13.09%) | (14.82%) | (17.40%) | (13.55%) | |
Free Cash Flow Yield |
5.89% | 5.43% | 6.93% | 3.79% | |
Revenue per Share |
1.62 | 1.49 | 1.47 | 1.44 | |
Operating CF per Share |
0.08 | 0.04 | 0.05 | 0.03 | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.07 | 0.02 | 0.03 | 0.01 | |
Cash per Share |
0.38 | 0.30 | 0.38 | 0.42 | |
Shareholders Equity per Share |
0.98 | 0.85 | 0.84 | 0.89 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.98 | 0.85 | 0.84 | 0.89 | |
Free Cash Flow |
5.79 | 1.99 | 2.62 | 0.75 | |
Working Capital |
34.69 | 30.22 | 29.38 | 26.39 | |
Capital Expenditures |
(1.31) | (1.29) | (1.61) | (2.03) | |
Net Current Asset Value |
(74.06) | (83.54) | (79.24) | (78.09) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
4.94 | 3.78 | 4.35 | 3.22 | |
Average Payables |
26.77 | 27.95 | 25.46 | 25.61 | |
Average Inventory |
35.53 | 36.07 | 34.72 | 34.84 | |
Average Assets |
227.01 | 208.42 | 207.79 | 215.04 | |
Average Common Equity |
95.16 | 87.08 | 87.80 | 90.14 |
Columns are period end dates · fundamentals updated 25 Oct 2026